Elsevier

Biochemical Pharmacology

Volume 15, Issue 12, December 1966, Pages 1965-1983
Biochemical Pharmacology

Biochemical properties of anti-inflammatory drugs—VIII: Inhibition of histamine formation catalysed by substrate-specific mammalian histidine decarboxylases. Drug antagonism of aldehyde binding to protein amino groups

https://doi.org/10.1016/0006-2952(66)90225-5Get rights and content

Abstract

Kinetic studies have shown that a number of acidic anti-inflammatory drugs (salicylate, “Ibufenac”, phenylbutazone, Indomethacin and Flufenamic acid) inhibit histamine formation by competing with pyridoxal phosphate for the coenzyme binding site, believed to be a lysyl ϵ-amino group on mammalian histidine decarboxylase. Apparent inhibitor constants (Ki's) for these drugs were measured.

These drugs also inhibited the binding of pyridoxal phosphate and 2,4,6-trinitro-benzaldehyde (TNBAL) to ϵ-amino groups of bovine plasma albumin at pH 7.5.

A number of chemical analogues of these drugs were screened for their ability to (i) inhibit histamine formation in vitro and to (ii) retard the formation of the red coloration which forms when TNBAL reacts with albumin at pH 7.5 (and provides a novel colorimetric method for testing potential drug activity).

Other compounds with notable drug activity in these two assays [(i) and (ii) above] include Sanochrysin, “Biogastrone”, pentachlorophenol and phenylindanedione—all of which, like the anti-inflammatory drugs named above, also uncouple oxidative phosphorylation.

References (53)

  • G. Kahlson et al.

    Lancet

    (1960)
  • M.J.H. Smith et al.

    Biochem. Pharmac.

    (1963)
  • A. Burkhalter

    Biochem. Pharmac.

    (1962)
  • R. Håkanson

    Biochem. Pharmac.

    (1963)
  • P.A. Shore et al.

    J. Pharmac. exp. Ther.

    (1959)
  • H. Fraenkel-Conrat
  • A.G. Gornall et al.

    J. biol. Chem.

    (1949)
  • S. Moore et al.

    J. biol. Chem.

    (1948)
  • M. Dixon

    Biochem. J.

    (1953)
  • M.W. Whitehouse

    J. Pharm. Pharmac.

    (1963)
  • L. Fontaine et al.

    Med. Pharmac. Exp.

    (1965)
  • H.B. Klevers et al.

    Disc. Faraday Soc.

    (1954)
  • R. Håkanson et al.

    Biochem. Pharmac.

    (1966)
  • T. Lewis

    The Blood Vessels of the Human Skin and Their Responses

    (1927)
  • R.W. Schayer
  • R.W. Schayer

    Ann. N.Y. Acad. Sci.

    (1964)
  • G. Kahlson

    Persp. biol. Med.

    (1962)
  • G. Kahlson
  • G. Kahlson et al.

    Experientia

    (1963)
  • B.J. Gould et al.

    Biochem. J.

    (1963)
  • B.J. Gould et al.

    J. Pharm. Pharmac.

    (1965)
  • A.K. Huggins et al.

    Biochem. J.

    (1961)
  • B.J. Gould et al.

    J. Pharm. Pharmac.

    (1965)
  • O. Hanninen et al.

    Biochem. J.

    (1964)
  • O. Hanninen et al.

    Biochem. Pharmac.

    (1964)
  • R. Pulver et al.

    Schweiz, med. Wschr.

    (1956)

    • Cited by (0)

    ∗

    Present address: Dept. of Experimental Pathology, John Curtin School of Medical Research, The Australian National University, Canberra, A.C.T., Australia.

    View full text
    Copyright © 1966 Published by Elsevier Inc.